Previous 10 | Next 10 |
Testing will be available through CLX Health’s TrustAssure™ Global Testing Platform for international travelers from New York and New Jersey who will need to complete testing immediately prior to travel. COVID-19 tests can be scheduled online and are available at Enz...
ipopba/iStock via Getty Images Enzo Biochem (ENZ) has risen ~5.6% in the pre-market after the company announced Q3 financials for fiscal 2021 yesterday indicating its continuing momentum in profitability. Enzo recorded quarterly operating profits for the third consecutive quarter with $2.0M o...
Enzo Biochem, Inc. (ENZ) Q3 2021 Earnings Conference Call June 9, 2021 16:30 ET Company Participants Jeremy Feffer - Investor Relations Barry Weiner - Co-Founder and President David Bench - Chief Financial Officer Conference Call Participants Andrew D’Silva - B. Riley Securities & ...
Total third quarter revenue of $32.8 million, a record quarterly high, increased 94% year-over-year Consolidated quarterly gross margin was 49% versus 26% in the previous year period, confirming Enzo’s vertically integrated approach can continue to drive healthy margins i...
NEW YORK, NY, June 01, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report third quarter 2021 financial results on Wednesday, June 9, 2021, after the market close. The announcement will be followed by a l...
Company’s specimen collection kit now available for use in COVID-19 testing in the U.S. Sample collection kit can be used with PCR based molecular diagnostic or antigen-based testing platforms NEW YORK, NY, April 21, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (...
The boardroom drama at Enzo Biochem (ENZ) took a new twist today when the company’s board of directors announced its decision to reject the resignation of founder Elazar Rabban as a director of the company. Enzo Biochem share are trading ~1.1% lower in after hours. “Th...
NEW YORK, NY, March 17, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today announced that management will present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum , Tuesday March 23 rd at 10:45am ET....
Harbert Discovery Fund, a leading investor of Enzo Biochem (ENZ) has praised the recent decisions taken by the company to conduct a CEO search with the support of global search firm Korn Ferry and the engagement of Cain Brothers to evaluate the strategic options.The company closed...
Gainers: SunLink Health Systems (SSY) +219%.Can-Fite BioPharma (CANF) +53%.Savara (SVRA) +37%.Fintech Acquisition (FTCVU) +31%.New Fortress Energy (NFE) +27%.Lizhi (LIZI) +26%.Enzo Biochem (ENZ) +25%.iSun (ISUN) +23%.Anchiano Therapeutics (ANCN) +21%.OptimizeRx (OPRX) +21%...
News, Short Squeeze, Breakout and More Instantly...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...
FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's...
FARMINGDALE, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments. Summary of the Fis...